Pityriasis rubra pilaris developing after COVID-19

Q4 Medicine

Turkderm-Archives of the Turkish Dermatology and Venerology Pub Date : 2022-03-22 DOI:10.4274/turkderm.galenos.2021.26235

M. Kuş, Perihan Öztürk, H. Nazik, M. Mülayim, Tutku Bulut, Esra Rabia Akgüç, S. Koçarslan

引用次数: 0

Abstract

Coronavirus disease-2019 (COVID-19) has been associated with multiple skin lesions as well as causing common respiratory symptoms. We presented a case of pityriasis rubra pilaris that developed after COVID-19 infection and treated with anti-tumor necrosis factor (adalimumab), which was not previously reported in an adult.

查看原文本刊更多论文

COVID-19后发生的毛状红斑糠疹

冠状病毒病-2019 (COVID-19)与多种皮肤病变以及引起常见的呼吸道症状有关。我们报告了一例在COVID-19感染后发生并使用抗肿瘤坏死因子(阿达木单抗)治疗的红色毛糙糠疹，该病例以前未在成人中报道。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊